Kristina A. Akmalova
2/1 Barrikadnaya Street
Moscow, MOW 123995, Russian Federation
Moscow, MOW 123995, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
The impact of ABCB1, CYP3A4 and CYP3A5 gene polymorphisms on apixaban trough concentration and bleeding risk in patients with atrial fibrillation.
Journal: Drug metabolism and personalized therapy
Published: March 03, 2024
Relationship of CYP3A4*1B Single Nucleotide Polymorphism to the Efficiency and Safety Profiles of Haloperidol in Patients Enduring Acute Alcoholic Hallucinosis.
Journal: Psychopharmacology bulletin
Published: December 11, 2023
Relationship of the 1846G > A Polymorphism of the CYP2D6 Gene to the Equilibrium Concentration Levels of Haloperidol in Patients with Acute Alcoholic Hallucinosis.
Journal: Psychopharmacology bulletin
Published: December 11, 2023
Association of CYP2D6*4 Polymorphism with the Steady-State Concentration of Haloperidol in Patients with Alcohol-Induced Psychotic Disorders.
Journal: Psychopharmacology bulletin
Published: November 07, 2022
Genetic Testing is Superior Over Endogenous Pharmacometabolomic Markers to Predict Safety of Haloperidol in Patients with Alcohol-induced Psychotic Disorder.
Journal: Current drug metabolism
Published: August 12, 2022
Correlation of 1846G>A Polymorphism of CYP2D6 Gene with Haloperidol Efficacy and Safety in Patients with Alcoholic Hallucinoses.
Journal: Psychopharmacology bulletin
Published: July 11, 2022
CYP2C9 gene polymorphisms influence on antihypertensive effectiveness and hypouricemic effect of losartan among patients with arterial hypertension: an observational study.
Journal: Drug metabolism and personalized therapy
Published: May 30, 2022
CYP2D6 gene polymorphic markers role in determining the optimal treatment tactics for portal hypertension in patients with liver cirrhosis
Journal: Terapevticheskii arkhiv
Published: March 28, 2022
Effect of CYP2D6*4, CYP2D6*10 polymorphisms on the safety of treatment with timolol maleate in patients with glaucoma.
Journal: Drug metabolism and personalized therapy
Published: March 08, 2022
MicroRNAs as Novel Biomarkers for P2Y12 - Inhibitors Resistance Prediction.
Journal: Pharmacogenomics and personalized medicine
Published: June 16, 2021
CYP2D6 phenotype and ABCB1 haplotypes are associated with antipsychotic safety in adolescents experiencing acute psychotic episodes.
Journal: Drug metabolism and personalized therapy
Published: April 07, 2021
Last Updated: 09/26/2026